Profil
Kathleen Large is a professional with experience in the pharmaceutical industry.
She is currently the Senior Vice President-Clinical Operations at Trillium Therapeutics ULC since 2019.
Previously, she worked as Vice President-Clinical Development at Histogenics Corp.
and as Vice President-Development Operations at Aileron Therapeutics, Inc. from 2018 to 2019.
Ms. Large completed her undergraduate degree at Boston College and her graduate degree at The University of California, San Francisco.
Anciens postes connus de Kathleen Large
| Sociétés | Poste | Fin |
|---|---|---|
| REIN THERAPEUTICS INC. | Corporate Officer/Principal | 01/01/2019 |
| TRILLIUM THERAPEUTICS | Directeur Technique/Scientifique/R&D | - |
| OCUGEN, INC. | Corporate Officer/Principal | - |
Formation de Kathleen Large
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Trillium Therapeutics, Inc.
Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Histogenics Corp.
Histogenics Corp. BiotechnologyHealth Technology Develops and commercializes regenerative medicine | Health Technology |
Rein Therapeutics, Inc.
Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















